About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
Investor FAQ
  > INVESTORS
  Overview
  Corporate Structure
  Corporate Governance
  Company History
  Annual General Meeting
  Postal Ballot
  Investor FAQs
  Stock Info
  Financial Results
  Subsidiary Financials
  Annual Report
  Disclosure to Stock Exchange
  Nomination form
  Press Releases
  Presentations
  Analyst Coverage
  Investor Contacts
  
  
     
 
Investor FAQs


- Corporate information
- Equity shares information
- Investor calendar


Corporate Information
 
1. What is Biocon's area of operations?
Biocon is a global provider of innovative biopharmaceutical products and research services that span the entire drug value chain: pre-clinical discovery to clinical development to commercialization. The Biocon group of companies consists of Biocon Limited, the flagship company and its eight subsidiaries – Syngene International Limited, Biocon Research Limited, Biocon Biologics Limited, Biocon SA, Neo Biocon FZ LLC, Biocon Pharma Limited, Biocon FZ LLC and Biocon Academy.

The Small Molecules vertical offers a strong portfolio of differentiated APIs across statins, immunosuppressants, specialty molecules and includes our Generic formulations business

The Biologics vertical comprises our Novel Biologics and Biosimilars, including rh-insulin, insulin analogs, monoclonal antibodies and recombinant proteins.

The Branded Formulations business includes our finished dosages business in India and overseas including UAE.

Custom & Clinical Research Services
Biocon provides contract research services to overseas and domestic customers in the following areas:
- Molecular Biology
- Biologics
- Synthetic Chemistry
- Bioinformatics
- Clinical research on well-defined and   characterised patients   suffering from chronic diseases such as diabetes,
  osteoporosis, asthma, etc.

2. What is the address of Biocon’s registered office?
Biocon has its corporate and registered office at Bangalore.

BIOCON LIMITED
20th KM, Hosur Road
Electronic City PO
Bangalore - 560 100
CIN:L24234KA1978PLC003417
Ph +91 80 2808 2808
Fax +91 80 2852 3423

3. Where and in which year was Biocon incorporated?
Biocon was incorporated on November 29, 1978 in Bangalore, India.

4. What is the total employee strength at Biocon Group?
Team Biocon comprises of 8000+ employees (as on Mar. 31, 2016) in various fields, with a strong scientist portfolio.

5. What is Biocon’s consolidated revenue and profits for the recently concluded period and for the last 12 months?
Rupees Crores FY15 FY16
 Revenues 3,143 3570
 Profit After Tax 497* 896*
* Incl. exceptional income

6. Where can I obtain information on Biocon’s financial results?
To obtain the financial results of the company, please refer to our website under the Investor Relations section here. Alternatively, the same is also available at the website of National Stock Exchange (NSE) and Mumbai Stock Exchange (BSE).
The results of the company are also published in leading Business Dailies.

7. Who are the members on Biocon’s Board of Directors?
Biocon's Board consists of:
Ms. Kiran Mazumdar-Shaw, Chairperson and Managing Director
Mr. John Shaw, Vice Chairman
Dr. Arun Chandavarkar, CEO & Jt. Managing Director
Prof Ravi Mazumdar
Mr. Russell Walls
Ms. Mary Harney
Mr. Daniel M. Bradbury
Dr. Jeremy Levin
Dr. Vijay Kumar Kuchroo
Mr. M. Damodaran
 
 
Equity Shares Information

1. When did Biocon have its Initial Public Offer (IPO) ?
In March 2004, Biocon went public with an IPO of 10,000,000 fresh equity shares of Rs. 5 each at a price of Rs. 315 per share.

2. On which stock exchanges are Biocon shares listed and what are the codes?
Name of Exchange Code
 National Stock Exchange, Mumbai (NSE) BIOCON
 Mumbai Stock Exchange, (BSE) 532523

3. Where can I obtain details on Biocon’s stockholders?
Details of shareholding pattern of the company is available on our website in the Investor Relations Section here. The same is also available on the NSE and BSE websites.

4. Does Biocon pay dividends?
The Company has been consistently paying dividend since 2004. For the fiscal year 2015-16, the company paid dividend of 100% (i.e., Rs. 5.00 per share)

5. What is the percentage breakdown of shareholders?
The broad shareholding pattern of Biocon as on Dec. 31, 2016
 ESOP Trust 1.78%
 Promoters 60.68%
 Public, Institutional and Others 37.53%
 
 
 

Investor Calendar

1. What is the date of release of financial results?
The tentative calendar for the financial results for the fiscal year 2016-17 is as follows:
 Q1 FY 2016-17  Released on July 21, 2016
 Q2 FY 2016-17  Released on October 20, 2016
 Q3 FY 2016-17  Released on January 24, 2017
 Q4 FY 2016-17  To be released on April 27, 2017

2. When is the next AGM?
The Annual General Meeting (AGM) of the Company for the year 2016-17 is tentatively scheduled for July 28, 2017

3. Does the Company have any quiet periods?
Yes. Biocon follows quiet periods prior to declaration of its quarterly results ie. starting from the 1st day immediately following the relevant calendar quarter till the second trading day after disclosure of such quarterly/ annual financial results. During this time, the Company or any of its officials will not discuss earnings expectations with any external parties.


 
 
     
Frequently Asked Questions
 
 
 
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2016, Biocon. All Rights Reserved